No direct, clinically documented interaction between cannabidiol (CBD) and memantine has been verified. A medication review still matters because side effects can complicate dementia care, while CBD's broader safety and interaction profile remains incomplete. Memantine treats moderate-to-severe Alzheimer's-type dementia. Reviewing the full medication list before adding CBD can uncover kidney, sedation, product, and symptom-overlap concerns that a simple interaction search may miss.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Is there a known CBD–memantine interaction?
- Why can side effects be mistaken for dementia changes?
- Does CBD improve dementia symptoms?
- What should a medication review cover?
Is there a known CBD–memantine interaction?
cbd can affect cytochrome P450, or CYP, enzymes that process many medicines. However, memantine undergoes little CYP metabolism and leaves the body largely through the kidneys. According to DailyMed's memantine prescribing information, CBD's CYP effects alone do not establish an interaction with memantine.
That does not prove the combination is risk-free. CBD may affect other medicines in the person's regimen, and severe kidney impairment increases memantine exposure. Urine-alkalinizing drugs also deserve review when assessing memantine use. The useful question is therefore broader than "Do these two products interact?" A clinician or pharmacist needs to assess the person, the complete regimen, and the exact CBD product.
Why can side effects be mistaken for dementia changes?
Memantine commonly causes dizziness and confusion. Those effects may resemble worsening dementia, making it difficult to identify the cause of a change in alertness, balance, or thinking. CBD can cause somnolence, meaning unusual sleepiness, as well as gastrointestinal symptoms, irritability, and agitation. The FDA's CBD consumer guidance also warns that CBD can alter the effects of other medicines. Timing can provide clues but not certainty.
For example, new sleepiness after starting CBD may involve CBD itself, another sedating medicine, or their combined effects. Increasing confusion could reflect memantine, dementia progression, or another medication issue. CBD has no FDA approval for dementia. Epidiolex, used for specified seizure disorders, remains the only FDA-approved CBD medicine. Nonapproved CBD products have not been evaluated by the FDA for an effective dose, interactions, or safety.
Does CBD improve dementia symptoms?
The evidence remains limited. In a small randomized vascular-dementia trial, 30 adults received either CBD at 300 milligrams daily or a placebo for four weeks. Behavioral-symptom scores improved with CBD, but cognition and daily function did not improve significantly. That result does not establish a dementia treatment or a general CBD dose.
The study was small and short, involved vascular dementia, and requires confirmation in larger, longer trials. A Cochrane review of four trials involving 126 people found the evidence too uncertain to determine meaningful benefit or harm. Those studies tested THC or synthetic THC-like drugs, not CBD, so they cannot answer whether CBD helps. Together, these findings offer a possible signal for behavioral symptoms but no established improvement in cognition or function. They also do not show that adding a nonapproved CBD product to memantine will produce a worthwhile benefit.
What should a medication review cover?
Bring the clinician or pharmacist enough information to assess the whole regimen, not merely the names "CBD" and "memantine": The reviewer can then separate a proposed benefit from a measurable safety concern. Before changing either product, bring the complete list and the CBD container or label to the prescriber or pharmacist.
- Every prescription and over-the-counter medicine
- Vitamins, herbs, and other supplements
- Alcohol and all cannabis products
- The CBD product name, labeled strength, dose, schedule, and reason for use
- Kidney-function information, particularly any severe impairment
